Bicalutamide Tablet, Film Coated
Product Images NDC 82804-082

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bicalutamide (NDC 82804-082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bicalutamide-figure-1 (Bicalutamide Figure 1)

Bicalutamide-figure-1 (Bicalutamide Figure 1)
A Kaplan-Meier survival curve graph showing the probability of death for two antiandrogen treatment groups over time. The y-axis represents the proportion surviving, and the x-axis shows days to death up to 1825 days. One curve represents bicalutamide plus LHRH-A and the other represents flutamide plus LHRH-A.*
FDA Label Image

Bicalutamide-figure-2 (Bicalutamide Figure 2)

Bicalutamide-figure-2 (Bicalutamide Figure 2)
A Kaplan-Meier curve chart showing time to progression for two antiandrogen treatment groups: bicalutamide plus LHRH-A and flutamide plus LHRH-A. The x-axis represents days to progression up to 1825 days, and the y-axis shows the proportion of patients not progressing, ranging from 0 to 1. Two lines depict patient progression over time for each treatment group.*
FDA Label Image

Bicalutamide-structure (Bicalutamide Structure)

Bicalutamide-structure (Bicalutamide Structure)
Chemical structure of bicalutamide, showing its molecular formula C18H14N2O4F3S. The diagram includes aromatic rings, a trifluoromethyl group, a cyano group, and other functional groups characteristic of bicalutamide.*
FDA Label Image

82804-082-90 (Spl Bicalutamide Tablets)

82804-082-90 (Spl Bicalutamide Tablets)
Bicalutamide 50 mg film-coated tablets label from Proficient Rx LP. The label states each tablet contains 50 mg of bicalutamide USP, describes the tablets as white to off-white, circular, biconvex, film-coated with '485' debossed on one side and plain on the other. Package contains 90 tablets. Manufactured by Sun Pharmaceutical Industries Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.